Caris Life Sciences Settles Medicare 14-Day Rule Claims for $2.88 Million
The company was facing allegations that it had intentionally delayed submitting lab tests in order to circumvent the rule and receive payment.
The company was facing allegations that it had intentionally delayed submitting lab tests in order to circumvent the rule and receive payment.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
Settlements for False Claims Act allegations the theme in recent enforcement actions involving the healthcare industry.
All of last week’s key cases announced by the DOJ involving the health care industry related to companies settling false claims-related allegations.